Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism

Autor: Dongjie Fan, Cecilia Portugal, Margaret C. Fang, Alan S. Go, Sue Hee Sung, Priya A. Prasad, Jin-Wen Hsu, Kristi Reynolds
Rok vydání: 2021
Předmět:
Zdroj: Journal of Thrombosis and Thrombolysis, vol 52, iss 4
Journal of Thrombosis and Thrombolysis
ISSN: 1573-742X
0929-5305
DOI: 10.1007/s11239-021-02437-z
Popis: Treatment options for patients with venous thromboembolism (VTE) include warfarin and direct oral anticoagulants (DOACs). Although DOACs are easier to administer than warfarin and do not require routine laboratory monitoring, few studies have directly assessed whether patients are more satisfied with DOACs. We surveyed adults from two large integrated health systems taking DOACs or warfarin for incident VTE occurring between January 1, 2015 and June 30, 2018. Treatment satisfaction was assessed using the validated Anti-Clot Treatment Scale (ACTS), divided into the ACTS Burdens and ACTS Benefits scores; higher scores indicate greater satisfaction. Mean treatment satisfaction was compared using multivariable linear regression, adjusting for patient demographic and clinical characteristics. The effect size of the difference in means was calculated using a Cohen’s d (0.20 is considered a small effect and ≥ 0.80 is considered large). We surveyed 2217 patients, 969 taking DOACs and 1248 taking warfarin at the time of survey. Thirty-one point five percent of the cohort was aged ≥ 75 years and 43.1% were women. DOAC users were on average more satisfied with anticoagulant treatment, with higher adjusted mean ACTS Burdens (50.18 v. 48.01, p
Databáze: OpenAIRE